Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis
Identifieur interne : 002D34 ( Main/Exploration ); précédent : 002D33; suivant : 002D35Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis
Auteurs : Pamela J. Hooper [États-Unis] ; Brian K. Chu [États-Unis] ; Alexei Mikhailov [Suisse] ; Eric A. Ottesen [États-Unis] ; Mark Bradley [Royaume-Uni]Source :
- PLoS Neglected Tropical Diseases [ 1935-2727 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Filaricides.
- épidémiologie : Filariose lymphatique.
- Filariose lymphatique, Humains, Modèles biologiques, Modèles statistiques, Santé mondiale, Santé publique, Évaluation des risques.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Filaricides.
- drug therapy : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- prevention & control : Elephantiasis, Filarial.
- Global Health, Humans, Models, Biological, Models, Statistical, Public Health, Risk Assessment.
Abstract
In 1997, the World Health Assembly adopted Resolution 50.29, committing to the elimination of lymphatic filariasis (LF) as a public health problem, subsequently targeted for 2020. The initial estimates were that 1.2 billion people were at-risk for LF infection globally. Now, 13 years after the Global Programme to Eliminate Lymphatic Filariasis (GPELF) began implementing mass drug administration (MDA) against LF in 2000—during which over 4.4 billion treatments have been distributed in 56 endemic countries—it is most appropriate to estimate the impact that the MDA has had on reducing the population at risk of LF.
To assess GPELF progress in reducing the population at-risk for LF, we developed a model based on defining reductions in risk of infection among cohorts of treated populations following each round of MDA. The model estimates that the number of people currently at risk of infection decreased by 46% to 789 million through 2012.
Important progress has been made in the global efforts to eliminate LF, but significant scale-up is required over the next 8 years to reach the 2020 elimination goal.
Url:
DOI: 10.1371/journal.pntd.0003333
PubMed: 25411843
PubMed Central: 4239000
Affiliations:
- Royaume-Uni, Suisse, États-Unis
- Angleterre, District de Columbia, Grand Londres, Géorgie (États-Unis)
- Londres, Washington (district de Columbia)
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000415
- to stream Pmc, to step Curation: 000415
- to stream Pmc, to step Checkpoint: 001D39
- to stream PubMed, to step Corpus: 001200
- to stream PubMed, to step Curation: 001200
- to stream PubMed, to step Checkpoint: 001200
- to stream Ncbi, to step Merge: 006D38
- to stream Ncbi, to step Curation: 006D38
- to stream Ncbi, to step Checkpoint: 006D38
- to stream Main, to step Merge: 002D39
- to stream Main, to step Curation: 002D34
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis</title><author><name sortKey="Hooper, Pamela J" sort="Hooper, Pamela J" uniqKey="Hooper P" first="Pamela J." last="Hooper">Pamela J. Hooper</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Chu, Brian K" sort="Chu, Brian K" uniqKey="Chu B" first="Brian K." last="Chu">Brian K. Chu</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Mikhailov, Alexei" sort="Mikhailov, Alexei" uniqKey="Mikhailov A" first="Alexei" last="Mikhailov">Alexei Mikhailov</name><affiliation wicri:level="1"><nlm:aff id="aff2"><addr-line>Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland</addr-line></nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Ottesen, Eric A" sort="Ottesen, Eric A" uniqKey="Ottesen E" first="Eric A." last="Ottesen">Eric A. Ottesen</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation><affiliation wicri:level="3"><nlm:aff id="aff3"><addr-line>ENVISION Project, RTI International, Washington D.C., United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>ENVISION Project, RTI International, Washington D.C.</wicri:regionArea><placeName><settlement type="city">Washington (district de Columbia)</settlement><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name><affiliation wicri:level="3"><nlm:aff id="aff4"><addr-line>Global Health Programs, GlaxoSmithKline, London, United Kingdom</addr-line></nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Global Health Programs, GlaxoSmithKline, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25411843</idno><idno type="pmc">4239000</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239000</idno><idno type="RBID">PMC:4239000</idno><idno type="doi">10.1371/journal.pntd.0003333</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000415</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000415</idno><idno type="wicri:Area/Pmc/Curation">000415</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000415</idno><idno type="wicri:Area/Pmc/Checkpoint">001D39</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001D39</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001200</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001200</idno><idno type="wicri:Area/PubMed/Curation">001200</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001200</idno><idno type="wicri:Area/PubMed/Checkpoint">001200</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001200</idno><idno type="wicri:Area/Ncbi/Merge">006D38</idno><idno type="wicri:Area/Ncbi/Curation">006D38</idno><idno type="wicri:Area/Ncbi/Checkpoint">006D38</idno><idno type="wicri:doubleKey">1935-2727:2014:Hooper P:assessing:progress:in</idno><idno type="wicri:Area/Main/Merge">002D39</idno><idno type="wicri:Area/Main/Curation">002D34</idno><idno type="wicri:Area/Main/Exploration">002D34</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis</title><author><name sortKey="Hooper, Pamela J" sort="Hooper, Pamela J" uniqKey="Hooper P" first="Pamela J." last="Hooper">Pamela J. Hooper</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Chu, Brian K" sort="Chu, Brian K" uniqKey="Chu B" first="Brian K." last="Chu">Brian K. Chu</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Mikhailov, Alexei" sort="Mikhailov, Alexei" uniqKey="Mikhailov A" first="Alexei" last="Mikhailov">Alexei Mikhailov</name><affiliation wicri:level="1"><nlm:aff id="aff2"><addr-line>Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland</addr-line></nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>Control of Neglected Tropical Diseases, World Health Organization, Geneva</wicri:regionArea><wicri:noRegion>Geneva</wicri:noRegion></affiliation></author><author><name sortKey="Ottesen, Eric A" sort="Ottesen, Eric A" uniqKey="Ottesen E" first="Eric A." last="Ottesen">Eric A. Ottesen</name><affiliation wicri:level="2"><nlm:aff id="aff1"><addr-line>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia, United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation><affiliation wicri:level="3"><nlm:aff id="aff3"><addr-line>ENVISION Project, RTI International, Washington D.C., United States of America</addr-line></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>ENVISION Project, RTI International, Washington D.C.</wicri:regionArea><placeName><settlement type="city">Washington (district de Columbia)</settlement><region type="state">District de Columbia</region></placeName></affiliation></author><author><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name><affiliation wicri:level="3"><nlm:aff id="aff4"><addr-line>Global Health Programs, GlaxoSmithKline, London, United Kingdom</addr-line></nlm:aff><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Global Health Programs, GlaxoSmithKline, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">PLoS Neglected Tropical Diseases</title><idno type="ISSN">1935-2727</idno><idno type="eISSN">1935-2735</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Filaricides (therapeutic use)</term><term>Global Health</term><term>Humans</term><term>Models, Biological</term><term>Models, Statistical</term><term>Public Health</term><term>Risk Assessment</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Modèles biologiques</term><term>Modèles statistiques</term><term>Santé mondiale</term><term>Santé publique</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Global Health</term><term>Humans</term><term>Models, Biological</term><term>Models, Statistical</term><term>Public Health</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Filariose lymphatique</term><term>Humains</term><term>Modèles biologiques</term><term>Modèles statistiques</term><term>Santé mondiale</term><term>Santé publique</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>In 1997, the World Health Assembly adopted Resolution 50.29, committing to the elimination of lymphatic filariasis (LF) as a public health problem, subsequently targeted for 2020. The initial estimates were that 1.2 billion people were at-risk for LF infection globally. Now, 13 years after the Global Programme to Eliminate Lymphatic Filariasis (GPELF) began implementing mass drug administration (MDA) against LF in 2000—during which over 4.4 billion treatments have been distributed in 56 endemic countries—it is most appropriate to estimate the impact that the MDA has had on reducing the population at risk of LF.</p></sec><sec><title>Methodology/Principal Findings</title><p>To assess GPELF progress in reducing the population at-risk for LF, we developed a model based on defining reductions in risk of infection among cohorts of treated populations following each round of MDA. The model estimates that the number of people currently at risk of infection decreased by 46% to 789 million through 2012.</p></sec><sec><title>Conclusions/Significance</title><p>Important progress has been made in the global efforts to eliminate LF, but significant scale-up is required over the next 8 years to reach the 2020 elimination goal.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Michael, E" uniqKey="Michael E">E Michael</name></author><author><name sortKey="Bundy, Da" uniqKey="Bundy D">DA Bundy</name></author><author><name sortKey="Grenfell, Bt" uniqKey="Grenfell B">BT Grenfell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ottesen, Ea" uniqKey="Ottesen E">EA Ottesen</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="De Jian, S" uniqKey="De Jian S">S De-Jian</name></author><author><name sortKey="Xu Li, D" uniqKey="Xu Li D">D Xu-Li</name></author><author><name sortKey="Ji Hui, D" uniqKey="Ji Hui D">D Ji-Hui</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Molyneux, Dh" uniqKey="Molyneux D">DH Molyneux</name></author><author><name sortKey="Zagaria, N" uniqKey="Zagaria N">N Zagaria</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ramzy, Rm" uniqKey="Ramzy R">RM Ramzy</name></author><author><name sortKey="El Setouhy, M" uniqKey="El Setouhy M">M El Setouhy</name></author><author><name sortKey="Helmy, H" uniqKey="Helmy H">H Helmy</name></author><author><name sortKey="Ahmed, Es" uniqKey="Ahmed E">ES Ahmed</name></author><author><name sortKey="Abd Elaziz, Km" uniqKey="Abd Elaziz K">KM Abd Elaziz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bockarie, Mj" uniqKey="Bockarie M">MJ Bockarie</name></author><author><name sortKey="Tisch, Dj" uniqKey="Tisch D">DJ Tisch</name></author><author><name sortKey="Kastens, W" uniqKey="Kastens W">W Kastens</name></author><author><name sortKey="Alexander, Nd" uniqKey="Alexander N">ND Alexander</name></author><author><name sortKey="Dimber, Z" uniqKey="Dimber Z">Z Dimber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schlemper, Br" uniqKey="Schlemper B">BR Schlemper</name></author><author><name sortKey="Steindel, M" uniqKey="Steindel M">M Steindel</name></author><author><name sortKey="Grisard, Ec" uniqKey="Grisard E">EC Grisard</name></author><author><name sortKey="Carvalho Pinto, Cj" uniqKey="Carvalho Pinto C">CJ Carvalho-Pinto</name></author><author><name sortKey="Bernardini, Oj" uniqKey="Bernardini O">OJ Bernardini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bockarie, Mj" uniqKey="Bockarie M">MJ Bockarie</name></author><author><name sortKey="Ibam, E" uniqKey="Ibam E">E Ibam</name></author><author><name sortKey="Alexander, Nd" uniqKey="Alexander N">ND Alexander</name></author><author><name sortKey="Hyun, P" uniqKey="Hyun P">P Hyun</name></author><author><name sortKey="Dimber, Z" uniqKey="Dimber Z">Z Dimber</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Das, Pk" uniqKey="Das P">PK Das</name></author><author><name sortKey="Ramaiah, Kd" uniqKey="Ramaiah K">KD Ramaiah</name></author><author><name sortKey="Vanamail, P" uniqKey="Vanamail P">P Vanamail</name></author><author><name sortKey="Pani, Sp" uniqKey="Pani S">SP Pani</name></author><author><name sortKey="Yuvaraj, J" uniqKey="Yuvaraj J">J Yuvaraj</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kimura, E" uniqKey="Kimura E">E Kimura</name></author><author><name sortKey="Spears, Gf" uniqKey="Spears G">GF Spears</name></author><author><name sortKey="Singh, Ki" uniqKey="Singh K">KI Singh</name></author><author><name sortKey="Samarawickrema, Wa" uniqKey="Samarawickrema W">WA Samarawickrema</name></author><author><name sortKey="Penaia, L" uniqKey="Penaia L">L Penaia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Richards, Fo" uniqKey="Richards F">FO Richards</name></author><author><name sortKey="Pam, Dd" uniqKey="Pam D">DD Pam</name></author><author><name sortKey="Kal, A" uniqKey="Kal A">A Kal</name></author><author><name sortKey="Gerlong, Gy" uniqKey="Gerlong G">GY Gerlong</name></author><author><name sortKey="Onyeka, J" uniqKey="Onyeka J">J Onyeka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Grady, Ca" uniqKey="Grady C">CA Grady</name></author><author><name sortKey="De Rochars, Mb" uniqKey="De Rochars M">MB de Rochars</name></author><author><name sortKey="Direny, An" uniqKey="Direny A">AN Direny</name></author><author><name sortKey="Orelus, Jn" uniqKey="Orelus J">JN Orelus</name></author><author><name sortKey="Wendt, J" uniqKey="Wendt J">J Wendt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ottesen, Ea" uniqKey="Ottesen E">EA Ottesen</name></author><author><name sortKey="Hooper, Pj" uniqKey="Hooper P">PJ Hooper</name></author><author><name sortKey="Bradley, M" uniqKey="Bradley M">M Bradley</name></author><author><name sortKey="Biswas, G" uniqKey="Biswas G">G Biswas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chu, Bk" uniqKey="Chu B">BK Chu</name></author><author><name sortKey="Hooper, Pj" uniqKey="Hooper P">PJ Hooper</name></author><author><name sortKey="Bradley, Mh" uniqKey="Bradley M">MH Bradley</name></author><author><name sortKey="Mcfarland, Da" uniqKey="Mcfarland D">DA McFarland</name></author><author><name sortKey="Ottesen, Ea" uniqKey="Ottesen E">EA Ottesen</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><affiliations><list><country><li>Royaume-Uni</li><li>Suisse</li><li>États-Unis</li></country><region><li>Angleterre</li><li>District de Columbia</li><li>Grand Londres</li><li>Géorgie (États-Unis)</li></region><settlement><li>Londres</li><li>Washington (district de Columbia)</li></settlement></list><tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Hooper, Pamela J" sort="Hooper, Pamela J" uniqKey="Hooper P" first="Pamela J." last="Hooper">Pamela J. Hooper</name></region><name sortKey="Chu, Brian K" sort="Chu, Brian K" uniqKey="Chu B" first="Brian K." last="Chu">Brian K. Chu</name><name sortKey="Ottesen, Eric A" sort="Ottesen, Eric A" uniqKey="Ottesen E" first="Eric A." last="Ottesen">Eric A. Ottesen</name><name sortKey="Ottesen, Eric A" sort="Ottesen, Eric A" uniqKey="Ottesen E" first="Eric A." last="Ottesen">Eric A. Ottesen</name></country><country name="Suisse"><noRegion><name sortKey="Mikhailov, Alexei" sort="Mikhailov, Alexei" uniqKey="Mikhailov A" first="Alexei" last="Mikhailov">Alexei Mikhailov</name></noRegion></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Bradley, Mark" sort="Bradley, Mark" uniqKey="Bradley M" first="Mark" last="Bradley">Mark Bradley</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002D34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4239000
|texte= Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25411843" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |